XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.23.2

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022
--- | --- | --- | ---
Investments at cost | $ 723,633 |  | $ 721,248
Investments at fair value | 715,391 |  | 720,026
Investment, Unaffiliated Issuer [Member] |  |  |
Investments at cost | 723,633 |  | 721,248
Investments at fair value | 714,485 |  | 720,026
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |
Investments at cost | 700,162 |  | 701,074
Investments at fair value | 683,309 |  | 686,458
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost | 15,061 |  | 14,790
Investments at fair value | 25,483 |  | 29,712
Investment, Unaffiliated Issuer [Member] | Other Long-Term Investments [Member] |  |  |
Investments at cost | 1,200 |  | 1,200
Investments at fair value | 1,300 |  | 1,300
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |
Investments at cost | 7,210 |  | 4,184
Investments at fair value | 4,393 |  | 2,556
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |
Investments at cost | 0 |  | 0
Investments at fair value | 906 | $ 846 | 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] |  |  |
Investments at cost | 0 |  |
Investments at fair value | 906 |  |
Biotechnology Sector [Member] |  |  |
Investments at cost | 182,489 |  | 193,372
Investments at fair value | 174,598 |  | 195,006
Medical Device Sector [Member] |  |  |
Investments at cost | 128,203 |  | 132,803
Investments at fair value | 130,634 |  | 135,960
Software Sector [Member] |  |  |
Investments at cost | 142,853 |  | 120,157
Investments at fair value | 139,934 |  | 118,716
Other Sustainability Sector [Member] |  |  |
Investments at cost | 86,095 |  | 84,633
Investments at fair value | 83,942 |  | 85,524
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |
Investments at cost | 85,173 |  |
Investments at fair value | 83,255 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost | 922 |  |
Investments at fair value | $ 687 |  |
Number of Shares (in shares) |  |  |
Diagnostics Sector [Member] |  |  |
Investments at cost | $ 9,960 |  | 9,851
Investments at fair value | 9,969 |  | 9,858
Communications Sector [Member] |  |  |
Investments at cost | 22,922 |  | 22,892
Investments at fair value | 26,170 |  | 26,176
Other Healthcare Sector [Member] |  |  |
Investments at cost | 101 |  | 7,559
Investments at fair value | 1,374 |  | 3,870
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |
Investments at cost | 302,687 |  | 318,172
Investments at fair value | 294,452 |  | 317,568
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost |  |  | 4,197
Investments at fair value |  |  | $ 9,792
Number of Shares (in shares) |  |  |
Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |
Investments at cost | 35,739 |  | $ 30,729
Investments at fair value | 35,739 |  | 25,819
Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost | 539 |  | 416
Investments at fair value | $ 2,136 |  | 1,953
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |
ETP |  |  |
Investments at cost | $ 276,563 |  | 268,468
Investments at fair value | 269,863 |  | 259,366
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost | 9,401 |  | 9,249
Investments at fair value | 16,392 |  | 16,148
Data Storage Sector [Member] |  |  |
Investments at cost | 417 |  | 476
Investments at fair value | 1,060 |  | 1,316
Internet and Media Sector [Member] |  |  |
Investments at cost | 329 |  | 329
Investments at fair value | 1,634 |  | 1,159
Networking Sector [Member] |  |  |
Investments at cost | 8,391 |  | 11,831
Investments at fair value | 8,274 |  | 11,710
Power Management Sector [Member] |  |  |
Investments at cost | 1,585 |  | 1,585
Investments at fair value | 2,898 |  | 2,610
Semiconductor Sector [Member] |  |  |
Investments at cost | 57 |  | 56
Investments at fair value | 0 |  | 0
Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost | 4,199 |  |
Investments at fair value | 6,268 |  |
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |
Investments at cost |  |  | 83,705
Investments at fair value |  |  | 83,705
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost |  |  | 928
Investments at fair value |  |  | $ 1,819
Number of Shares (in shares) |  |  |
Software, Healthcare Information and Service [Member] |  |  |
Investments at cost | 26,217 |  | $ 13,735
Investments at fair value | $ 26,532 |  | $ 14,044
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Jan. 01, 2025 |  | Jan. 01, 2025
Principal Amount | $ 2,055 |  | $ 2,885
Investments at cost | 2,011 |  | 2,853
Investments at fair value | $ 1,938 |  | $ 2,777
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Jan. 01, 2025 |  | Jan. 01, 2025
Principal Amount | $ 2,028 |  | $ 2,885
Investments at cost | 1,982 |  | 2,823
Investments at fair value | 1,910 |  | 2,750
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 311 |  | 311
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 26,444 |  | 26,442
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Jan. 01, 2025 |  | Jan. 01, 2025
Principal Amount | $ 1,014 |  | $ 1,442
Investments at cost | 991 |  | 1,411
Investments at fair value | $ 955 |  | $ 1,374
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Feb. 01, 2025 |  | Feb. 01, 2025
Principal Amount | $ 2,028 |  | $ 2,885
Investments at cost | 1,980 |  | 2,821
Investments at fair value | $ 1,907 |  | $ 2,748
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Feb. 01, 2025 |  | Feb. 01, 2025
Principal Amount | $ 2,028 |  | $ 2,885
Investments at cost | 1,980 |  | 2,821
Investments at fair value | $ 1,907 |  | $ 2,748
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Apr. 01, 2025 |  | Apr. 01, 2025
Principal Amount | $ 1,014 |  | $ 1,442
Investments at cost | 987 |  | 1,408
Investments at fair value | $ 951 |  | $ 1,371
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Apr. 01, 2025 |  | Apr. 01, 2025
Principal Amount | $ 1,014 |  | $ 1,442
Investments at cost | 987 |  | 1,408
Investments at fair value | $ 951 |  | $ 1,371
Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 8.75% |  | 8.75%
Ceiling | 0.00% |  | 0.00%
ETP | 6.00% |  | 6.00%
Maturity Date | Oct. 01, 2025 |  | Oct. 01, 2025
Principal Amount | $ 4,750 |  | $ 5,000
Investments at cost | 4,680 |  | 4,914
Investments at fair value | $ 4,680 |  | $ 4,914
Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 8.75% |  | 8.75%
Ceiling | 0.00% |  | 0.00%
ETP | 6.00% |  | 6.00%
Maturity Date | Oct. 01, 2025 |  | Oct. 01, 2025
Principal Amount | $ 2,375 |  | $ 2,500
Investments at cost | 2,338 |  | 2,457
Investments at fair value | 2,338 |  | 2,457
Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 264 |  | 264
Investments at fair value | $ 125 |  | $ 37
Number of Shares (in shares) | 318,181 |  | 318,181
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.50% |  | 12.25%
Margin | 5.25% |  | 5.25%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 3,500 |  | $ 3,500
Investments at cost | 3,460 |  | 3,349
Investments at fair value | $ 3,460 |  | $ 3,349
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.50% |  | 12.25%
Margin | 5.25% |  | 5.25%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 3,500 |  | $ 3,500
Investments at cost | 3,460 |  | 3,454
Investments at fair value | 3,460 |  | 3,454
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 71 |  | 71
Investments at fair value | $ 84 |  | $ 83
Number of Shares (in shares) | 135,484 |  | 135,484
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.50% |  |
Margin | 5.25% |  |
Floor | 9.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jul. 01, 2027 |  |
Principal Amount | $ 3,500 |  |
Investments at cost | 3,450 |  |
Investments at fair value | $ 3,450 |  |
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 13.50% |  |
Margin | 5.25% |  |
Floor | 9.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jul. 01, 2027 |  |
Principal Amount | $ 3,500 |  |
Investments at cost | 3,450 |  |
Investments at fair value | $ 3,450 |  |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,602 |  | 3,478
Investments at fair value | $ 3,602 |  | $ 3,478
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 1,250 |  | $ 1,250
Investments at cost | 1,240 |  | 1,238
Investments at fair value | 1,240 |  | 1,238
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 95 |  | 56
Investments at fair value | $ 276 |  | $ 233
Number of Shares (in shares) | 37,294 |  | 31,966
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,720 |  | 3,715
Investments at fair value | $ 3,720 |  | $ 3,715
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 1,250 |  | $ 1,250
Investments at cost | 1,240 |  | 1,238
Investments at fair value | $ 1,240 |  | $ 1,238
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,720 |  | 3,715
Investments at fair value | $ 3,720 |  | $ 3,715
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 1,250 |  | $ 1,250
Investments at cost | 1,240 |  | 1,238
Investments at fair value | $ 1,240 |  | $ 1,238
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,705 |  | 3,698
Investments at fair value | $ 3,705 |  | $ 3,698
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |  |
Cash Rate | 11.25% |  | 11.25%
Margin | 6.00% |  | 6.00%
Floor | 9.50% |  | 9.50%
Ceiling | 11.25% |  | 11.25%
ETP | 3.00% |  | 3.00%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,700 |  | 3,698
Investments at fair value | $ 3,700 |  | $ 3,698
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Nine [Member] |  |  |
Cash Rate | 11.25% |  |
Margin | 6.00% |  |
Floor | 9.50% |  |
Ceiling | 11.25% |  |
ETP | 3.00% |  |
Maturity Date | Apr. 01, 2028 |  |
Principal Amount | $ 3,750 |  |
Investments at cost | 3,705 |  |
Investments at fair value | $ 3,705 |  |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Ten [Member] |  |  |
Cash Rate | 11.25% |  |
Margin | 6.00% |  |
Floor | 9.50% |  |
Ceiling | 11.25% |  |
ETP | 3.00% |  |
Maturity Date | Jul. 01, 2028 |  |
Principal Amount | $ 3,750 |  |
Investments at cost | 3,698 |  |
Investments at fair value | $ 3,698 |  |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |
Cash Rate | 11.25% |  |
Margin | 6.00% |  |
Floor | 9.50% |  |
Ceiling | 11.25% |  |
ETP | 3.00% |  |
Maturity Date | Jul. 01, 2028 |  |
Principal Amount | $ 3,750 |  |
Investments at cost | 3,698 |  |
Investments at fair value | $ 3,698 |  |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Twelve [Member] |  |  |
Cash Rate | 11.25% |  |
Margin | 6.00% |  |
Floor | 9.50% |  |
Ceiling | 11.25% |  |
ETP | 3.00% |  |
Maturity Date | Jul. 01, 2028 |  |
Principal Amount | $ 1,250 |  |
Investments at cost | 1,250 |  |
Investments at fair value | $ 1,250 |  |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Thirteen [Member] |  |  |
Cash Rate | 11.25% |  |
Margin | 6.00% |  |
Floor | 9.50% |  |
Ceiling | 11.25% |  |
ETP | 3.00% |  |
Maturity Date | Jul. 01, 2028 |  |
Principal Amount | $ 1,250 |  |
Investments at cost | 1,250 |  |
Investments at fair value | $ 1,250 |  |
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.75% |  | 14.00%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 3.50% |  | 3.50%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 6,500 |  | $ 6,500
Investments at cost | 6,370 |  | 6,347
Investments at fair value | $ 6,370 |  | $ 6,347
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.75% |  | 14.00%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 3.50% |  | 3.50%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 6,000 |  | $ 6,000
Investments at cost | 5,880 |  | 5,859
Investments at fair value | 5,880 |  | 5,859
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost |  |  | 455
Investments at fair value |  |  | $ 197
Number of Shares (in shares) |  |  | 516,732
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 455 |  |
Investments at fair value | $ 169 |  |
Number of Shares (in shares) | 516,732 |  |
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.75% |  | 14.00%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 3.50% |  | 3.50%
Maturity Date | Aug. 01, 2026 |  | Aug. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,447 |  | 2,436
Investments at fair value | $ 2,447 |  | $ 2,436
Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 12.25%
Margin |  |  | 5.25%
Floor |  |  | 8.50%
Ceiling |  |  | 0.00%
ETP |  |  | 20.00%
Maturity Date |  |  | Sep. 15, 2022
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,500
Investments at fair value |  |  | $ 2,500
Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 12.25%
Margin |  |  | 5.25%
Floor |  |  | 8.50%
Ceiling |  |  | 0.00%
ETP |  |  | 20.00%
Maturity Date |  |  | Sep. 15, 2022
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,500
Investments at fair value |  |  | $ 2,500
Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,710 |  | 3,699
Investments at fair value | $ 3,585 |  | $ 3,699
Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,710 |  | 3,699
Investments at fair value | 3,585 |  | 3,699
Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 61 |  | 61
Investments at fair value | $ 0 |  | $ 74
Number of Shares (in shares) | 201,537 |  | 201,537
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.25% |  | 13.50%
Margin | 6.00% |  | 6.00%
Floor | 9.25% |  | 9.25%
Ceiling | 0.00% |  | 0.00%
ETP | 3.50% |  | 3.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,478 |  | 2,385
Investments at fair value | $ 2,478 |  | $ 2,385
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.25% |  | 13.50%
Margin | 6.00% |  | 6.00%
Floor | 9.25% |  | 9.25%
Ceiling | 0.00% |  | 0.00%
ETP | 3.50% |  | 3.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,478 |  | 2,473
Investments at fair value | 2,478 |  | 2,473
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 47 |  | 47
Investments at fair value | $ 56 |  | $ 54
Number of Shares (in shares) | 171,370 |  | 159,893
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.25% |  | 13.50%
Margin | 6.00% |  | 6.00%
Floor | 9.25% |  | 9.25%
Ceiling | 0.00% |  | 0.00%
ETP | 3.50% |  | 3.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,957 |  | 4,946
Investments at fair value | $ 4,957 |  | $ 4,946
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.25% |  | 13.00%
Margin | 6.00% |  | 6.00%
Floor | 9.25% |  | 9.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2026
Principal Amount | $ 7,500 |  | $ 7,500
Investments at cost | 7,462 |  | 7,455
Investments at fair value | $ 7,462 |  | $ 7,455
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.25% |  | 13.00%
Margin | 6.00% |  | 6.00%
Floor | 9.25% |  | 9.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2026
Principal Amount | $ 7,500 |  | $ 7,500
Investments at cost | 7,462 |  | 7,455
Investments at fair value | 7,462 |  | 7,455
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 45 |  | 46
Investments at fair value | $ 67 |  | $ 67
Number of Shares (in shares) | 1,991 |  | 1,991
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.25% |  | 13.00%
Margin | 6.00% |  | 6.00%
Floor | 9.25% |  | 9.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2026
Principal Amount | $ 7,500 |  | $ 7,500
Investments at cost | 7,462 |  | 7,455
Investments at fair value | 7,462 |  | $ 7,455
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Convertible Debt Securities [Member] |  |  |
Cash Rate |  |  | 3.00%
Maturity Date |  |  | Jul. 01, 2023
Principal Amount |  |  | $ 250
Investments at cost |  |  | 250
Investments at fair value |  |  | $ 306
Axiom Space, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] |  |  |
Investments at cost | 261 |  |
Investments at fair value | $ 306 |  |
Number of Shares (in shares) | 1,810 |  |
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 6.00% |  | 6.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,471 |  | 2,463
Investments at fair value | $ 2,358 |  | $ 2,364
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 6.00% |  | 6.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,471 |  | 2,463
Investments at fair value | 2,358 |  | 2,364
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 48 |  | 48
Investments at fair value | $ 32 |  | $ 31
Number of Shares (in shares) | 27,330 |  | 27,330
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.13% |  | 12.50%
Margin | 4.88% |  | 6.05%
Floor | 9.55% |  | 9.55%
Ceiling | 13.50% |  | 13.50%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,899 |  | 4,891
Investments at fair value | $ 4,899 |  | $ 4,891
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.13% |  | 12.50%
Margin | 4.88% |  | 6.05%
Floor | 9.55% |  | 9.55%
Ceiling | 13.50% |  | 13.50%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,971 |  | 4,963
Investments at fair value | 4,971 |  | 4,963
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 212 |  | 214
Investments at fair value | $ 338 |  | $ 335
Number of Shares (in shares) | 7,404 |  | 7,404
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.13% |  | 12.50%
Margin | 4.88% |  | 6.05%
Floor | 9.55% |  | 9.55%
Ceiling | 13.50% |  | 13.50%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 3,000 |  | $ 3,000
Investments at cost | 2,982 |  | 2,978
Investments at fair value | $ 2,982 |  | $ 2,978
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 13.13% |  | 12.50%
Margin | 4.88% |  | 6.05%
Floor | 9.55% |  | 9.55%
Ceiling | 13.50% |  | 13.50%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,971 |  | 4,963
Investments at fair value | $ 4,971 |  | $ 4,963
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 13.13% |  | 12.50%
Margin | 4.88% |  | 6.05%
Floor | 9.55% |  | 9.55%
Ceiling | 13.50% |  | 13.50%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,971 |  | 4,963
Investments at fair value | $ 4,971 |  | $ 4,963
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 13.13% |  | 12.50%
Margin | 4.88% |  | 6.05%
Floor | 9.55% |  | 9.55%
Ceiling | 13.50% |  | 13.50%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 3,000 |  | $ 3,000
Investments at cost | 2,982 |  | 2,978
Investments at fair value | 2,982 |  | 2,978
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |  |
Investments at cost | 250 |  | 250
Investments at fair value | $ 250 |  | $ 250
Number of Shares (in shares) | 1,162 |  | 1,162
LiquiGlide, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 36 |  | $ 39
Investments at fair value | $ 56 |  | $ 55
Number of Shares (in shares) | 61,359 |  | 61,539
Kate Farms, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 101 |  | $ 102
Investments at fair value | $ 1,374 |  | $ 1,370
Number of Shares (in shares) | 82,965 |  | 82,965
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.34% |  |
Margin | 5.09% |  |
Floor | 10.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jan. 01, 2024 |  |
Principal Amount | $ 875 |  |
Investments at cost | 867 |  |
Investments at fair value | $ 867 |  |
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.34% |  |
Margin | 5.09% |  |
Floor | 10.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jan. 01, 2024 |  |
Principal Amount | $ 58 |  |
Investments at cost | 58 |  |
Investments at fair value | 58 |  |
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 150 |  | $ 153
Investments at fair value | $ 154 |  | $ 150
Number of Shares (in shares) | 1,375,727 |  | 1,375,727
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.34% |  |
Margin | 5.09% |  |
Floor | 10.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Mar. 01, 2024 |  |
Principal Amount | $ 1,200 |  |
Investments at cost | 1,191 |  |
Investments at fair value | 1,191 |  |
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |  |
Cash Rate |  |  | 12.37%
Margin |  |  | 8.20%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 5.00%
Maturity Date |  |  | Jan. 01, 2024
Principal Amount |  |  | $ 1,625
Investments at cost |  |  | 1,610
Investments at fair value |  |  | $ 1,610
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |
Cash Rate |  |  | 12.37%
Margin |  |  | 8.20%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 5.00%
Maturity Date |  |  | Jan. 01, 2024
Principal Amount |  |  | $ 108
Investments at cost |  |  | 107
Investments at fair value |  |  | $ 107
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |
Cash Rate |  |  | 12.37%
Margin |  |  | 8.20%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 5.00%
Maturity Date |  |  | Mar. 01, 2024
Principal Amount |  |  | $ 2,000
Investments at cost |  |  | 1,983
Investments at fair value |  |  | 1,983
Intelepeer Holdings, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 138 |  | 139
Investments at fair value | $ 3,272 |  | $ 3,265
Number of Shares (in shares) | 2,936,535 |  | 2,936,535
Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.50% |  | 4.50%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,723 |  | 3,678
Investments at fair value | $ 3,723 |  | $ 3,678
Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.50% |  | 4.50%
Maturity Date | Jul. 01, 2027 |  | Jul. 01, 2027
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,723 |  | 3,718
Investments at fair value | 3,723 |  | 3,718
Corvium, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 53 |  | 53
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 661,956 |  | 661,956
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 490 |  |
Investments at fair value | $ 0 |  |
Number of Shares (in shares) | 213,746 |  |
BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.75% |  |
Margin | 5.50% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Aug. 01, 2027 |  |
Principal Amount | $ 7,000 |  |
Investments at cost | 6,670 |  |
Investments at fair value | $ 6,670 |  |
BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.75% |  |
Margin | 5.50% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Aug. 01, 2027 |  |
Principal Amount | $ 3,500 |  |
Investments at cost | 3,455 |  |
Investments at fair value | 3,455 |  |
BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 167 |  |
Investments at fair value | $ 181 |  |
Number of Shares (in shares) | 85,066 |  |
BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.75% |  |
Margin | 5.50% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Aug. 01, 2027 |  |
Principal Amount | $ 3,500 |  |
Investments at cost | 3,455 |  |
Investments at fair value | $ 3,455 |  |
BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 13.75% |  |
Margin | 5.50% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Apr. 01, 2028 |  |
Principal Amount | $ 2,750 |  |
Investments at cost | 2,706 |  |
Investments at fair value | 2,706 |  |
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 12.50%
Margin |  |  | 5.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Aug. 01, 2027
Principal Amount |  |  | $ 7,000
Investments at cost |  |  | 6,619
Investments at fair value |  |  | $ 6,619
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 12.50%
Margin |  |  | 5.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Aug. 01, 2027
Principal Amount |  |  | $ 3,500
Investments at cost |  |  | 3,448
Investments at fair value |  |  | 3,448
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | 160
Investments at fair value |  |  | $ 170
Number of Shares (in shares) |  |  | 80,544
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate |  |  | 12.50%
Margin |  |  | 5.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Aug. 01, 2027
Principal Amount |  |  | $ 3,500
Investments at cost |  |  | 3,448
Investments at fair value |  |  | 3,448
PebblePost, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 92 |  | 92
Investments at fair value | $ 139 |  | $ 173
Number of Shares (in shares) | 598,850 |  | 598,850
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 11.75% |  | 10.50%
Margin | 3.50% |  | 3.50%
Floor | 8.25% |  | 8.25%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | Oct. 01, 2024 |  | Oct. 01, 2024
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,981 |  | 4,973
Investments at fair value | $ 4,981 |  | $ 4,973
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 11.75% |  | 10.50%
Margin | 3.50% |  | 3.50%
Floor | 8.25% |  | 8.25%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | Oct. 01, 2024 |  | Oct. 01, 2024
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,981 |  | 4,973
Investments at fair value | 4,981 |  | 4,973
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 69 |  | 69
Investments at fair value | $ 211 |  | $ 209
Number of Shares (in shares) | 145,483 |  | 145,483
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 11.75% |  | 10.50%
Margin | 3.50% |  | 3.50%
Floor | 8.25% |  | 8.25%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | Oct. 01, 2024 |  | Oct. 01, 2024
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,485 |  | 2,478
Investments at fair value | $ 2,485 |  | $ 2,478
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 11.75% |  | 10.50%
Margin | 3.50% |  | 3.50%
Floor | 8.25% |  | 8.25%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | Oct. 01, 2024 |  | Oct. 01, 2024
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,485 |  | 2,478
Investments at fair value | $ 2,485 |  | 2,478
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 12.97% |  |
Margin | 4.72% |  |
Floor | 9.75% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jun. 01, 2024 |  |
Principal Amount | $ 1,979 |  |
Investments at cost | 1,968 |  |
Investments at fair value | $ 1,968 |  |
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 12.97% |  |
Margin | 4.72% |  |
Floor | 9.75% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jun. 01, 2024 |  |
Principal Amount | $ 1,979 |  |
Investments at cost | 1,969 |  |
Investments at fair value | 1,969 |  |
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 175 |  | 176
Investments at fair value | $ 264 |  | $ 263
Number of Shares (in shares) | 110,402 |  | 110,402
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 12.97% |  |
Margin | 4.72% |  |
Floor | 9.75% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Nov. 01, 2025 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,936 |  |
Investments at fair value | $ 4,936 |  |
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |  |
Cash Rate |  |  | 12.07%
Margin |  |  | 7.90%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 5.00%
Maturity Date |  |  | Jun. 01, 2024
Principal Amount |  |  | $ 1,979
Investments at cost |  |  | 1,962
Investments at fair value |  |  | $ 1,962
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 12.97% |  |
Margin | 4.72% |  |
Floor | 9.75% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | May 01, 2026 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,930 |  |
Investments at fair value | 4,930 |  |
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |
Cash Rate |  |  | 12.07%
Margin |  |  | 7.90%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 5.00%
Maturity Date |  |  | Jun. 01, 2024
Principal Amount |  |  | $ 1,979
Investments at cost |  |  | 1,963
Investments at fair value |  |  | $ 1,963
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |
Cash Rate |  |  | 12.07%
Margin |  |  | 7.90%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 5.00%
Maturity Date |  |  | Nov. 01, 2025
Principal Amount |  |  | $ 5,000
Investments at cost |  |  | 4,923
Investments at fair value |  |  | 4,923
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |  |
Investments at cost | 356 |  | 356
Investments at fair value | $ 356 |  | $ 356
Number of Shares (in shares) | 32,831 |  | 32,831
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Four [Member] |  |  |
Cash Rate |  |  | 12.07%
Margin |  |  | 7.90%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 5.00%
Maturity Date |  |  | May 01, 2026
Principal Amount |  |  | $ 5,000
Investments at cost |  |  | 4,912
Investments at fair value |  |  | $ 4,912
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.75% |  | 2.75%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 5,000 |  | $ 2,500
Investments at cost | 4,942 |  | 2,463
Investments at fair value | $ 4,942 |  | $ 2,463
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.75% |  | 2.75%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 2,500 |  | $ 5,000
Investments at cost | 2,471 |  | 4,927
Investments at fair value | 2,471 |  | 4,927
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 214 |  | 214
Investments at fair value | $ 365 |  | $ 361
Number of Shares (in shares) | 681 |  | 681
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.75% |  | 2.75%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,940 |  | 4,924
Investments at fair value | $ 4,940 |  | $ 4,924
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.75% |  | 2.75%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,470 |  | 2,462
Investments at fair value | $ 2,470 |  | $ 2,462
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 11.75% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.75% |  | 2.75%
Maturity Date | Dec. 01, 2026 |  | Dec. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,917 |  | 4,900
Investments at fair value | $ 4,917 |  | $ 4,900
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 11.75% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.75% |  | 2.75%
Maturity Date | Dec. 01, 2026 |  | Dec. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,458 |  | 2,450
Investments at fair value | 2,458 |  | 2,450
Medsphere Systems Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 61 |  |
Investments at fair value | $ 362 |  |
Number of Shares (in shares) | 7,097,792 |  |
Medsphere Systems Corporation [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | 60
Investments at fair value |  |  | $ 359
Number of Shares (in shares) |  |  | 7,097,792
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 13.75%
Margin |  |  | 6.75%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Jan. 01, 2025
Principal Amount |  |  | $ 5,000
Investments at cost |  |  | 4,966
Investments at fair value |  |  | $ 4,966
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 13.75%
Margin |  |  | 6.75%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Jan. 01, 2025
Principal Amount |  |  | $ 5,000
Investments at cost |  |  | 4,966
Investments at fair value |  |  | 4,966
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 93 |  | 93
Investments at fair value | $ 0 |  | $ 64
Number of Shares (in shares) | 20,000 |  | 20,000
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate |  |  | 13.75%
Margin |  |  | 6.75%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Jan. 01, 2025
Principal Amount |  |  | $ 3,000
Investments at cost |  |  | 2,979
Investments at fair value |  |  | $ 2,979
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate |  |  | 13.75%
Margin |  |  | 6.75%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Dec. 01, 2025
Principal Amount |  |  | $ 1,000
Investments at cost |  |  | 976
Investments at fair value |  |  | $ 976
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate |  |  | 13.75%
Margin |  |  | 6.75%
Floor |  |  | 10.00%
Ceiling |  |  | 0.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Feb. 01, 2026
Principal Amount |  |  | $ 1,000
Investments at cost |  |  | 977
Investments at fair value |  |  | $ 977
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 10,000 |  | $ 10,000
Investments at cost | 9,860 |  | 9,826
Investments at fair value | $ 9,860 |  | $ 9,826
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 10,000 |  | $ 10,000
Investments at cost | 9,860 |  | 9,826
Investments at fair value | 9,860 |  | 9,826
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 273 |  | 273
Investments at fair value | $ 299 |  | $ 296
Number of Shares (in shares) | 639,918 |  | 639,918
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,930 |  | 4,913
Investments at fair value | $ 4,930 |  | $ 4,913
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,930 |  | 4,913
Investments at fair value | $ 4,930 |  | $ 4,913
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 12.50% |  | 11.75%
Margin | 4.25% |  | 4.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.25% |  | 4.25%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 10,000 |  | $ 10,000
Investments at cost | 9,887 |  | 9,872
Investments at fair value | $ 9,887 |  | $ 9,872
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 12.50% |  | 11.75%
Margin | 4.25% |  | 4.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.25% |  | 4.25%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 15,000 |  | $ 15,000
Investments at cost | 14,830 |  | 14,808
Investments at fair value | 14,830 |  | 14,808
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 126 |  | 126
Investments at fair value | $ 0 |  | $ 125
Number of Shares (in shares) | 23,196 |  | 463,915
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 12.50% |  | 11.75%
Margin | 4.25% |  | 4.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.25% |  | 4.25%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 6,000 |  | $ 6,000
Investments at cost | 5,932 |  | 5,923
Investments at fair value | $ 5,932 |  | $ 5,923
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 12.50% |  | 11.75%
Margin | 4.25% |  | 4.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.25% |  | 4.25%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 6,000 |  | $ 6,000
Investments at cost | 5,932 |  | 5,923
Investments at fair value | $ 5,932 |  | $ 5,923
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 12.50% |  | 11.75%
Margin | 4.25% |  | 4.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.25% |  | 4.25%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 4,000 |  | $ 4,000
Investments at cost | 3,955 |  | 3,949
Investments at fair value | $ 3,955 |  | $ 3,949
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 12.50% |  | 11.75%
Margin | 4.25% |  | 4.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.25% |  | 4.25%
Maturity Date | Jan. 01, 2028 |  | Jan. 01, 2028
Principal Amount | $ 4,000 |  | $ 4,000
Investments at cost | 3,955 |  | 3,949
Investments at fair value | $ 3,955 |  | $ 3,949
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2025
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,709 |  | 3,697
Investments at fair value | $ 3,709 |  | $ 3,697
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Jun. 01, 2026 |  | Jun. 01, 2025
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,723 |  | 3,717
Investments at fair value | 3,723 |  | 3,717
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 121 |  | 126
Investments at fair value | $ 266 |  | $ 268
Number of Shares (in shares) | 34,604 |  | 35,906
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Oct. 01, 2026 |  | Oct. 01, 2025
Principal Amount | $ 7,500 |  | $ 7,500
Investments at cost | 7,436 |  | 7,424
Investments at fair value | $ 7,436 |  | $ 7,424
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Oct. 01, 2026 |  | Oct. 01, 2025
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,718 |  | 3,712
Investments at fair value | $ 3,718 |  | $ 3,712
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Oct. 01, 2026 |  | Oct. 01, 2025
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,718 |  | 3,712
Investments at fair value | $ 3,718 |  | $ 3,712
SafelyYou, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 11.50% |  |
Margin | 3.25% |  |
Floor | 11.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jun. 01, 2027 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,635 |  |
Investments at fair value | $ 4,635 |  |
SafelyYou, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 11.50% |  |
Margin | 3.25% |  |
Floor | 11.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Jun. 01, 2027 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,905 |  |
Investments at fair value | 4,905 |  |
SafelyYou, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 163 |  |
Investments at fair value | $ 163 |  |
Number of Shares (in shares) | 150,353 |  |
Embody, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 14.00%
Margin |  |  | 6.50%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 28.00%
Maturity Date |  |  | Aug. 01, 2026
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,482
Investments at fair value |  |  | 2,482
Aterian, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 195 |  | 195
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 76,923 |  | 76,923
Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2025 |  | Jul. 01, 2025
Principal Amount | $ 4,000 |  | $ 5,000
Investments at cost | 3,886 |  | 4,857
Investments at fair value | $ 3,859 |  | $ 4,857
Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Jul. 01, 2025 |  | Jul. 01, 2025
Principal Amount | $ 2,000 |  | $ 2,500
Investments at cost | 1,944 |  | 2,430
Investments at fair value | 1,931 |  | 2,430
Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 366 |  | 366
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 47,452 |  | 47,452
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Oct. 01, 2024 |  | Oct. 01, 2024
Principal Amount | $ 2,771 |  | $ 3,208
Investments at cost | 2,724 |  | 3,143
Investments at fair value | $ 2,724 |  | $ 3,143
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Jun. 01, 2025 |  | Jun. 01, 2025
Principal Amount | $ 1,000 |  | $ 1,000
Investments at cost | 979 |  | 974
Investments at fair value | 979 |  | 974
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 124 |  | 124
Investments at fair value | $ 52 |  | $ 113
Number of Shares (in shares) | 317,647 |  | 317,647
F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 13.25%
Margin |  |  | 6.25%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Apr. 01, 2025
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,476
Investments at fair value |  |  | $ 2,476
F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 13.25%
Margin |  |  | 6.25%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Jul. 01, 2025
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,473
Investments at fair value |  |  | 2,473
F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost |  |  | 35
Investments at fair value |  |  | $ 0
Number of Shares (in shares) |  |  | 21,120
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling |  |  | 0.00%
ETP | 1.85% |  | 1.85%
Maturity Date | Jul. 01, 2025 |  | Jul. 01, 2025
Principal Amount | $ 5,104 |  | $ 5,000
Investments at cost | 5,056 |  | 4,951
Investments at fair value | $ 3,426 |  | $ 3,834
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.50% |  | 13.75%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 1.85% |  | 1.85%
Maturity Date | Oct. 01, 2025 |  | Oct. 01, 2025
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,474 |  | 2,474
Investments at fair value | 1,677 |  | 1,916
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 26 |  | 26
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 10,690 |  | 10,690
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.50% |  |
Margin | 6.25% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 100.00% |  |
Maturity Date | Sep. 30, 2023 |  |
Principal Amount | $ 150 |  |
Investments at cost | 150 |  |
Investments at fair value | $ 102 |  |
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 14.50% |  |
Margin | 6.25% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 100.00% |  |
Maturity Date | Sep. 30, 2023 |  |
Principal Amount | $ 250 |  |
Investments at cost | 250 |  |
Investments at fair value | $ 169 |  |
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 14.50% |  |
Margin | 6.25% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 100.00% |  |
Maturity Date | Sep. 30, 2023 |  |
Principal Amount | $ 250 |  |
Investments at cost | 250 |  |
Investments at fair value | $ 169 |  |
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.25% |  | 14.50%
Margin | 7.00% |  | 7.00%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Aug. 27, 2025 |  | Sep. 01, 2025
Principal Amount | $ 7,500 |  | $ 7,500
Investments at cost | 7,395 |  | 7,371
Investments at fair value | $ 7,024 |  | $ 7,371
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.25% |  | 14.50%
Margin | 7.00% |  | 7.00%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Aug. 27, 2025 |  | Sep. 01, 2025
Principal Amount | $ 7,500 |  | $ 7,500
Investments at cost | 7,395 |  | 7,371
Investments at fair value | $ 7,024 |  | 7,371
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost |  |  | 488
Investments at fair value |  |  | $ 1,061
Number of Shares (in shares) |  |  | 204,832
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 15.25% |  | 14.50%
Margin | 7.00% |  | 7.00%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Aug. 27, 2025 |  | Sep. 01, 2025
Principal Amount | $ 7,500 |  | $ 7,500
Investments at cost | 7,395 |  | 7,371
Investments at fair value | $ 7,024 |  | $ 7,371
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 15.25% |  | 14.50%
Margin | 7.00% |  | 7.00%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Jun. 08, 2026 |  | Jul. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,922 |  | 4,903
Investments at fair value | $ 4,675 |  | $ 4,903
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 15.25% |  | 14.50%
Margin | 7.00% |  | 7.00%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Jun. 08, 2026 |  | Jul. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,922 |  | 4,903
Investments at fair value | $ 4,675 |  | 4,903
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 15.25% |  |
Margin | 7.00% |  |
Floor | 10.25% |  |
Ceiling | 0.00% |  |
ETP | 0.00% |  |
Maturity Date | Sep. 30, 2023 |  |
Principal Amount | $ 680 |  |
Investments at cost | 680 |  |
Investments at fair value | $ 646 |  |
Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |
Cash Rate | 15.25% |  |
Margin | 7.00% |  |
Floor | 10.25% |  |
Ceiling | 0.00% |  |
ETP | 0.00% |  |
Maturity Date | Sep. 30, 2023 |  |
Principal Amount | $ 542 |  |
Investments at cost | 542 |  |
Investments at fair value | 515 |  |
Imunon, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 66 |  | 66
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 19,671 |  | 16,502
Caastle, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 67 |  | $ 68
Investments at fair value | $ 1,058 |  | $ 1,069
Number of Shares (in shares) | 268,591 |  | 268,591
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 8.75% |  | 8.75%
Ceiling | 0.00% |  | 0.00%
ETP | 6.00% |  | 6.00%
Maturity Date | Aug. 01, 2026 |  | Aug. 01, 2026
Principal Amount | $ 5,000 |  | $ 2,500
Investments at cost | 4,948 |  | 2,466
Investments at fair value | $ 4,948 |  | $ 2,466
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 8.75% |  | 8.75%
Ceiling | 0.00% |  | 0.00%
ETP | 6.00% |  | 6.00%
Maturity Date | Aug. 01, 2026 |  | Aug. 01, 2026
Principal Amount | $ 2,500 |  | $ 5,000
Investments at cost | 2,474 |  | 4,932
Investments at fair value | 2,474 |  | 4,932
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 145 |  | 148
Investments at fair value | $ 178 |  | $ 179
Number of Shares (in shares) | 4,106,174 |  | 775,000
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jul. 01, 2025 |  | Jul. 01, 2025
Principal Amount | $ 5,035 |  | $ 5,000
Investments at cost | 4,988 |  | 4,946
Investments at fair value | $ 2,814 |  | $ 4,946
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jul. 01, 2025 |  | Jul. 01, 2025
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,476 |  | 2,473
Investments at fair value | 1,397 |  | 2,473
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 67 |  | 67
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 39,774 |  | 39,774
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jan. 01, 2026 |  | Jan. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,953 |  | 4,947
Investments at fair value | $ 2,795 |  | $ 4,947
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jan. 01, 2026 |  | Jan. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,953 |  | 4,947
Investments at fair value | 2,794 |  | 4,947
Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] |  |  |
Investments at cost | 1,200 |  | 1,200
Investments at fair value | 1,100 |  | 1,100
Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |  |
Investments at cost | 2,000 |  | 2,000
Investments at fair value | $ 1,700 |  | $ 1,700
Number of Shares (in shares) | 392,651 |  | 392,651
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.25% |  | 12.00%
Margin | 5.00% |  | 5.00%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Mar. 01, 2025 |  | Mar. 01, 2025
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,953 |  | 4,939
Investments at fair value | $ 4,953 |  | $ 4,939
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.25% |  | 12.00%
Margin | 5.00% |  | 5.00%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Mar. 01, 2025 |  | Mar. 01, 2025
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,953 |  | 4,939
Investments at fair value | 4,953 |  | 4,939
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 194 |  | 194
Investments at fair value | $ 390 |  | $ 385
Number of Shares (in shares) | 809,931 |  | 809,931
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.25% |  | 12.00%
Margin | 5.00% |  | 5.00%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Mar. 01, 2025 |  | Mar. 01, 2025
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,948 |  | 4,933
Investments at fair value | $ 4,948 |  | $ 4,933
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 13.25% |  | 12.00%
Margin | 5.00% |  | 5.00%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Mar. 01, 2025 |  | Mar. 01, 2025
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,949 |  | 4,933
Investments at fair value | $ 4,949 |  | $ 4,933
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 13.25% |  | 12.50%
Margin | 5.00% |  | 5.00%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Jan. 01, 2027 |  | Jan. 01, 2027
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,927 |  | 4,913
Investments at fair value | $ 4,927 |  | $ 4,913
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 13.25% |  | 12.50%
Margin | 5.00% |  | 5.00%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Jan. 01, 2027 |  | Jan. 01, 2027
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,927 |  | 4,913
Investments at fair value | $ 4,927 |  | $ 4,913
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.25% |  | 12.50%
Margin | 5.00% |  | 5.00%
Floor | 5.00% |  | 5.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Mar. 01, 2027 |  | Mar. 01, 2027
Principal Amount | $ 2,000 |  | $ 2,000
Investments at cost | 1,250 |  | 1,082
Investments at fair value | $ 1,250 |  | $ 1,082
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.25% |  | 12.50%
Margin | 5.00% |  | 5.00%
Floor | 5.00% |  | 5.00%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Mar. 01, 2027 |  | Mar. 01, 2027
Principal Amount | $ 3,000 |  | $ 3,000
Investments at cost | 1,875 |  | 1,623
Investments at fair value | 1,875 |  | 1,623
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 2,947 |  | 2,947
Investments at fair value | $ 2,677 |  | $ 2,947
Number of Shares (in shares) | 1,312,500 |  | 1,312,500
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 11.75% |  | 11.00%
Margin | 3.50% |  | 3.50%
Floor | 10.50% |  | 10.50%
Ceiling | 0.00% |  | 0.00%
ETP | 7.78% |  | 7.78%
Maturity Date | Feb. 01, 2028 |  | Feb. 01, 2028
Principal Amount | $ 2,813 |  | $ 2,813
Investments at cost | 2,813 |  | 2,813
Investments at fair value | $ 2,813 |  | $ 2,813
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 11.75% |  | 11.00%
Margin | 3.50% |  | 3.50%
Floor | 10.50% |  | 10.50%
Ceiling | 0.00% |  | 0.00%
ETP | 7.78% |  | 7.78%
Maturity Date | Feb. 01, 2028 |  | Feb. 01, 2028
Principal Amount | $ 2,813 |  | $ 2,813
Investments at cost | 2,813 |  | 2,813
Investments at fair value | $ 2,813 |  | $ 2,813
CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.50% |  | 14.75%
Margin | 7.25% |  | 7.25%
Floor | 10.50% |  | 10.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 3,500 |  | $ 3,500
Investments at cost | 3,467 |  | 3,461
Investments at fair value | 3,467 |  | 3,461
CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 22 |  | 20
Investments at fair value | $ 30 |  | $ 61
Number of Shares (in shares) | 75,997 |  | 17,605
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.75% |  | 14.00%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Mar. 01, 2026 |  | Mar. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,959 |  | 4,947
Investments at fair value | $ 4,959 |  | $ 4,947
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.75% |  | 14.00%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 2.50% |  | 2.50%
Maturity Date | Mar. 01, 2026 |  | Mar. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,480 |  | 2,474
Investments at fair value | 2,480 |  | 2,474
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 34 |  | 34
Investments at fair value | $ 41 |  | $ 41
Number of Shares (in shares) | 101,308 |  | 101,308
KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.00% |  | 12.25%
Margin | 4.75% |  | 4.75%
Floor | 8.50% |  | 8.50%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2027 |  | May 01, 2027
Principal Amount | $ 6,250 |  | $ 6,250
Investments at cost | 6,188 |  | 6,077
Investments at fair value | $ 6,188 |  | $ 6,077
KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.00% |  | 12.25%
Margin | 4.75% |  | 4.75%
Floor | 8.50% |  | 8.50%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | May 01, 2027 |  | May 01, 2027
Principal Amount | $ 6,250 |  | $ 6,250
Investments at cost | 6,188 |  | 6,177
Investments at fair value | 6,188 |  | 6,177
KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 50 |  | 51
Investments at fair value | $ 58 |  | $ 60
Number of Shares (in shares) | 48,076 |  | 48,077
ZetrOZ, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] |  |  |
Investments at cost | $ 0 |  | $ 0
Investments at fair value | $ 200 |  | $ 200
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | Aug. 01, 2025 |  | Aug. 01, 2025
Principal Amount | $ 2,083 |  | $ 2,500
Investments at cost | 2,069 |  | 2,482
Investments at fair value | $ 2,069 |  | $ 2,482
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.50% |  | 5.50%
Maturity Date | Aug. 01, 2025 |  | Aug. 01, 2025
Principal Amount | $ 2,083 |  | $ 2,500
Investments at cost | 2,069 |  | 2,482
Investments at fair value | 2,069 |  | 2,482
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 30 |  | 30
Investments at fair value | $ 126 |  | $ 125
Number of Shares (in shares) | 46,745 |  | 46,745
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.07% |  |
Margin | 4.82% |  |
Floor | 9.25% |  |
Ceiling | 0.00% |  |
ETP | 10.36% |  |
Maturity Date | Jul. 01, 2025 |  |
Principal Amount | $ 3,960 |  |
Investments at cost | 3,910 |  |
Investments at fair value | $ 3,910 |  |
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.07% |  |
Margin | 4.82% |  |
Floor | 9.25% |  |
Ceiling | 0.00% |  |
ETP | 10.36% |  |
Maturity Date | Jul. 01, 2025 |  |
Principal Amount | $ 3,960 |  |
Investments at cost | 3,910 |  |
Investments at fair value | 3,910 |  |
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 221 |  | $ 221
Investments at fair value | $ 229 |  | $ 226
Number of Shares (in shares) | 7,972,222 |  | 7,972,222
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |  |
Cash Rate |  |  | 12.17%
Margin |  |  | 8.00%
Floor |  |  | 9.25%
Ceiling |  |  | 0.00%
ETP |  |  | 10.36%
Maturity Date |  |  | Jul. 01, 2025
Principal Amount |  |  | $ 3,960
Investments at cost |  |  | 3,898
Investments at fair value |  |  | $ 3,898
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |
Cash Rate |  |  | 12.17%
Margin |  |  | 8.00%
Floor |  |  | 9.25%
Ceiling |  |  | 0.00%
ETP |  |  | 10.36%
Maturity Date |  |  | Jul. 01, 2025
Principal Amount |  |  | $ 3,960
Investments at cost |  |  | 3,898
Investments at fair value |  |  | 3,898
Mustang Bio, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 146 |  | 146
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 16,611 |  | 252,161
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.25% |  | 13.00%
Margin | 6.00% |  | 6.00%
Floor | 12.25% |  | 9.25%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Nov. 01, 2026 |  | Jul. 01, 2025
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,414 |  | 2,396
Investments at fair value | $ 2,414 |  | $ 2,396
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.25% |  | 13.00%
Margin | 6.00% |  | 6.00%
Floor | 12.25% |  | 12.25%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Dec. 01, 2026 |  | Dec. 01, 2026
Principal Amount | $ 1,250 |  | $ 1,250
Investments at cost | 1,234 |  | 1,231
Investments at fair value | 1,234 |  | 1,231
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 46 |  | 40
Investments at fair value | $ 18 |  | $ 44
Number of Shares (in shares) | 85,543 |  | 80,197
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.25% |  |
Margin | 6.00% |  |
Floor | 12.25% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Apr. 01, 2027 |  |
Principal Amount | $ 1,000 |  |
Investments at cost | 985 |  |
Investments at fair value | $ 985 |  |
Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.50% |  | 12.75%
Margin | 5.25% |  | 5.25%
Floor | 8.50% |  | 8.50%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Nov. 01, 2026 |  | Nov. 01, 2026
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,711 |  | 3,630
Investments at fair value | $ 3,711 |  | $ 3,630
Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.50% |  | 12.75%
Margin | 5.25% |  | 5.25%
Floor | 8.50% |  | 8.50%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Nov. 01, 2026 |  | Nov. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,475 |  | 2,469
Investments at fair value | 2,475 |  | 2,469
Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 64 |  | 64
Investments at fair value | $ 163 |  | $ 162
Number of Shares (in shares) | 103,679 |  | 103,679
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 3.75% |  | 3.75%
Maturity Date | Sep. 01, 2026 |  | Sep. 01, 2026
Principal Amount | $ 10,000 |  | $ 10,000
Investments at cost | 9,727 |  | 9,701
Investments at fair value | $ 9,727 |  | $ 9,701
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 3.75% |  | 3.75%
Maturity Date | Sep. 01, 2026 |  | Sep. 01, 2026
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,707 |  | 3,697
Investments at fair value | 3,707 |  | 3,697
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 160 |  | 160
Investments at fair value | $ 651 |  | $ 3,024
Number of Shares (in shares) | 299,848 |  | 299,848
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 3.75% |  | 3.75%
Maturity Date | Sep. 01, 2026 |  | Sep. 01, 2026
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,707 |  | 3,697
Investments at fair value | $ 3,707 |  | $ 3,697
Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 13.50%
Margin |  |  | 6.50%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Jan. 01, 2026
Principal Amount |  |  | $ 3,210
Investments at cost |  |  | 3,151
Investments at fair value |  |  | $ 0
Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 13.50%
Margin |  |  | 6.50%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Jan. 01, 2026
Principal Amount |  |  | $ 2,963
Investments at cost |  |  | 2,886
Investments at fair value |  |  | 0
Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | 103
Investments at fair value |  |  | $ 0
Number of Shares (in shares) |  |  | 553,710
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.61% |  |
Margin | 5.36% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 5.50% |  |
Maturity Date | Dec. 01, 2024 |  |
Principal Amount | $ 4,667 |  |
Investments at cost | 4,605 |  |
Investments at fair value | $ 4,605 |  |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.61% |  |
Margin | 5.36% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 5.50% |  |
Maturity Date | Dec. 01, 2024 |  |
Principal Amount | $ 4,667 |  |
Investments at cost | 4,605 |  |
Investments at fair value | 4,605 |  |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 442 |  | $ 399
Investments at fair value | $ 173 |  | $ 648
Number of Shares (in shares) | 293,488 |  | 203,017
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.61% |  |
Margin | 5.36% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 5.50% |  |
Maturity Date | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 |  |
Investments at cost | 2,289 |  |
Investments at fair value | $ 2,289 |  |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |  |
Cash Rate |  |  | 12.67%
Margin |  |  | 8.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 5.50%
Maturity Date |  |  | Dec. 01, 2024
Principal Amount |  |  | $ 4,667
Investments at cost |  |  | 4,597
Investments at fair value |  |  | $ 4,597
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 13.61% |  |
Margin | 5.36% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 5.50% |  |
Maturity Date | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 |  |
Investments at cost | 2,289 |  |
Investments at fair value | $ 2,289 |  |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |
Cash Rate |  |  | 12.67%
Margin |  |  | 8.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 5.50%
Maturity Date |  |  | Dec. 01, 2024
Principal Amount |  |  | $ 4,667
Investments at cost |  |  | 4,597
Investments at fair value |  |  | $ 4,597
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 13.61% |  |
Margin | 5.36% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 5.50% |  |
Maturity Date | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 |  |
Investments at cost | 2,284 |  |
Investments at fair value | $ 2,284 |  |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |
Cash Rate |  |  | 12.67%
Margin |  |  | 8.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 5.50%
Maturity Date |  |  | Dec. 01, 2024
Principal Amount |  |  | $ 2,333
Investments at cost |  |  | 2,280
Investments at fair value |  |  | $ 2,280
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 13.61% |  |
Margin | 5.36% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 5.50% |  |
Maturity Date | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 |  |
Investments at cost | 2,284 |  |
Investments at fair value | 2,284 |  |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Four [Member] |  |  |
Cash Rate |  |  | 12.67%
Margin |  |  | 8.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 5.50%
Maturity Date |  |  | Dec. 01, 2024
Principal Amount |  |  | $ 2,333
Investments at cost |  |  | 2,280
Investments at fair value |  |  | $ 2,280
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Five [Member] |  |  |
Cash Rate |  |  | 12.67%
Margin |  |  | 8.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 5.50%
Maturity Date |  |  | Dec. 01, 2024
Principal Amount |  |  | $ 2,333
Investments at cost |  |  | 2,274
Investments at fair value |  |  | $ 2,274
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Six [Member] |  |  |
Cash Rate |  |  | 12.67%
Margin |  |  | 8.50%
Floor |  |  | 9.50%
Ceiling |  |  | 0.00%
ETP |  |  | 5.50%
Maturity Date |  |  | Dec. 01, 2024
Principal Amount |  |  | $ 2,333
Investments at cost |  |  | 2,274
Investments at fair value |  |  | 2,274
Getaround, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |  |
Investments at cost | 253 |  | 253
Investments at fair value | $ 30 |  | $ 57
Number of Shares (in shares) | 87,082 |  | 87,082
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Oct. 01, 2025 |  | Oct. 01, 2025
Principal Amount | $ 4,667 |  | $ 5,000
Investments at cost | 4,635 |  | 4,954
Investments at fair value | $ 4,635 |  | $ 4,954
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.00% |  | 14.25%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Oct. 01, 2025 |  | Oct. 01, 2025
Principal Amount | $ 2,333 |  | $ 2,500
Investments at cost | 2,317 |  | 2,477
Investments at fair value | 2,317 |  | 2,477
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 29 |  | 29
Investments at fair value | $ 61 |  | $ 37
Number of Shares (in shares) | 250 |  | 143
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.25% |  |
Margin | 5.00% |  |
Floor | 12.00% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Mar. 01, 2027 |  |
Principal Amount | $ 10,000 |  |
Investments at cost | 9,741 |  |
Investments at fair value | $ 9,741 |  |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.25% |  |
Margin | 5.00% |  |
Floor | 12.00% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Mar. 01, 2027 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,932 |  |
Investments at fair value | 4,932 |  |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 116 |  |
Investments at fair value | $ 120 |  |
Number of Shares (in shares) | 84,037 |  |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.25% |  |
Margin | 5.00% |  |
Floor | 12.00% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Mar. 01, 2027 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,933 |  |
Investments at fair value | $ 4,933 |  |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 5,352 |  | $ 5,000
Investments at cost | 5,304 |  | 4,943
Investments at fair value | $ 4,630 |  | $ 4,715
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 2,141 |  | $ 2,000
Investments at cost | 2,124 |  | 1,981
Investments at fair value | $ 1,854 |  | 1,890
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | 197
Investments at fair value |  |  | $ 17
Number of Shares (in shares) |  |  | 1,261,253
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 2,676 |  | $ 2,500
Investments at cost | 2,658 |  | 2,477
Investments at fair value | $ 2,320 |  | $ 2,363
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 3,211 |  | $ 3,000
Investments at cost | 3,189 |  | 2,971
Investments at fair value | $ 2,784 |  | $ 2,835
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 2,676 |  | $ 2,500
Investments at cost | 2,644 |  | 2,459
Investments at fair value | $ 2,308 |  | $ 2,345
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 2,676 |  | $ 2,500
Investments at cost | 2,644 |  | 2,459
Investments at fair value | $ 2,308 |  | $ 2,345
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 5,351 |  | $ 5,000
Investments at cost | 5,287 |  | 4,914
Investments at fair value | $ 4,614 |  | $ 4,688
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |  |
Cash Rate | 14.00% |  | 12.75%
Margin | 5.75% |  | 5.75%
Floor | 9.00% |  | 9.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.25% |  | 2.00%
Maturity Date | Oct. 31, 2023 |  | Dec. 30, 2022
Principal Amount | $ 2,676 |  | $ 2,500
Investments at cost | 2,642 |  | 2,456
Investments at fair value | 2,306 |  | $ 2,342
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred and Common Stock [Member] |  |  |
Investments at cost | 197 |  |
Investments at fair value | $ 0 |  |
Number of Shares (in shares) | 1,237,370 |  |
NextCar Holding Company, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 89 |  |
Investments at fair value | $ 89 |  |
Number of Shares (in shares) | 2,688,971 |  |
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Nov. 01, 2026 |  | Nov. 01, 2026
Principal Amount | $ 3,500 |  | $ 3,500
Investments at cost | 3,417 |  | 3,360
Investments at fair value | $ 3,417 |  | $ 3,360
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.75% |  | 13.00%
Margin | 5.50% |  | 5.50%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Nov. 01, 2026 |  | Nov. 01, 2026
Principal Amount | $ 3,500 |  | $ 3,500
Investments at cost | 3,467 |  | 3,460
Investments at fair value | 3,467 |  | 3,460
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 16 |  | 16
Investments at fair value | $ 16 |  | $ 16
Number of Shares (in shares) | 86,066 |  | 86,066
Lyrical Foods, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 10.75% |  | 10.00%
Margin | 2.50% |  | 6.75%
Floor | 8.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 0.00% |  | 0.00%
Maturity Date | Sep. 01, 2027 |  | Sep. 01, 2027
Principal Amount | $ 2,598 |  | $ 2,500
Investments at cost | 2,589 |  | 2,588
Investments at fair value | 2,330 |  | 2,279
vTv Therapeutics Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | 44 |  | 44
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 95,293 |  | 95,293
SnagAJob.com, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |  |
Investments at cost | $ 9 |  | $ 8
Investments at fair value | $ 83 |  | $ 83
Number of Shares (in shares) | 82,974 |  | 82,974
Rocket Pharmaceuticals Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost |  |  | $ 17
Investments at fair value |  |  | $ 14
Number of Shares (in shares) |  |  | 7,051
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Aug. 01, 2027 |  | Aug. 01, 2027
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,400 |  | 2,347
Investments at fair value | $ 2,400 |  | 2,347
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.50% |  |
Margin | 6.25% |  |
Floor | 9.50% |  |
Ceiling | 0.00% |  |
ETP | 4.00% |  |
Maturity Date | Jul. 01, 2028 |  |
Principal Amount | $ 1,875 |  |
Investments at cost | 1,779 |  |
Investments at fair value | 1,779 |  |
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 182 |  | 104
Investments at fair value | $ 182 |  | $ 104
Number of Shares (in shares) | 11,550 |  | 6,600
Xeris Pharmaceuticals, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 72 |  | $ 72
Investments at fair value | $ 58 |  | $ 3
Number of Shares (in shares) | 126,000 |  | 126,000
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 13.00% |  | 11.75%
Margin | 4.75% |  | 4.75%
Floor | 8.50% |  | 8.50%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jan. 01, 2027 |  | Jan. 01, 2027
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,659 |  | 3,597
Investments at fair value | $ 3,659 |  | $ 3,597
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 13.00% |  | 11.75%
Margin | 4.75% |  | 4.75%
Floor | 8.50% |  | 8.50%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Jan. 01, 2027 |  | Jan. 01, 2027
Principal Amount | $ 3,750 |  | $ 3,750
Investments at cost | 3,714 |  | 3,706
Investments at fair value | 3,714 |  | 3,706
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 57 |  | 40
Investments at fair value | $ 64 |  | $ 46
Number of Shares (in shares) | 27,036 |  | 19,662
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 13.50% |  |
Margin | 5.25% |  |
Floor | 9.00% |  |
Ceiling | 0.00% |  |
ETP | 5.00% |  |
Maturity Date | Mar. 01, 2027 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,928 |  |
Investments at fair value | $ 4,928 |  |
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.50% |  | 14.25%
Margin | 7.25% |  | 7.25%
Floor | 10.50% |  | 10.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Mar. 01, 2025 |  | Mar. 01, 2025
Principal Amount | $ 2,000 |  | $ 2,700
Investments at cost | 1,980 |  | 2,673
Investments at fair value | $ 1,980 |  | $ 2,673
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.50% |  | 14.25%
Margin | 7.25% |  | 7.25%
Floor | 10.50% |  | 10.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Mar. 01, 2025 |  | Mar. 01, 2025
Principal Amount | $ 2,000 |  | $ 2,700
Investments at cost | 1,980 |  | 2,673
Investments at fair value | 1,980 |  | 2,673
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 57 |  | 57
Investments at fair value | $ 595 |  | $ 429
Number of Shares (in shares) | 553,778 |  | 553,778
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 15.50% |  | 14.25%
Margin | 7.25% |  | 7.25%
Floor | 10.50% |  | 10.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Sep. 01, 2025 |  | Sep. 01, 2025
Principal Amount | $ 2,600 |  | $ 3,000
Investments at cost | 2,573 |  | 2,967
Investments at fair value | $ 2,573 |  | $ 2,967
Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.50% |  | 14.25%
Margin | 7.25% |  | 7.25%
Floor | 10.50% |  | 10.50%
Ceiling | 0.00% |  | 0.00%
ETP | 3.00% |  | 3.00%
Maturity Date | Aug. 01, 2025 |  | Aug. 01, 2025
Principal Amount | $ 4,333 |  | $ 5,000
Investments at cost | 4,278 |  | 4,932
Investments at fair value | 4,278 |  | 4,932
Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 56 |  | 56
Investments at fair value | $ 50 |  | $ 39
Number of Shares (in shares) | 3,731 |  | 3,731
AccuVein Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 24 |  |
Investments at fair value | $ 0 |  |
Number of Shares (in shares) | 1,175 |  |
AccuVein Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost |  |  | $ 24
Investments at fair value |  |  | $ 0
Number of Shares (in shares) |  |  | 1,175
Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |  |
Number of Shares (in shares) | 5,205 |  |
Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] |  |  |
Investments at cost | $ 111 |  | $ 8
Investments at fair value | 97 |  | $ 27
Number of Shares (in shares) |  |  | 22,313
Quip NYC Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 325 |  | $ 325
Investments at fair value | $ 536 |  | $ 534
Number of Shares (in shares) | 6,191 |  | 6,191
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Aug. 01, 2026 |  | Aug. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,946 |  | 4,870
Investments at fair value | $ 4,946 |  | $ 4,870
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Aug. 01, 2026 |  | Aug. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,946 |  | 4,933
Investments at fair value | 4,946 |  | 4,933
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 123 |  | 123
Investments at fair value | $ 135 |  | $ 133
Number of Shares (in shares) | 309,208 |  | 309,208
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Aug. 01, 2026 |  | Aug. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,882 |  | 4,933
Investments at fair value | $ 4,882 |  | $ 4,933
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 14.00% |  | 13.25%
Margin | 5.75% |  | 5.75%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Aug. 01, 2026 |  | Aug. 01, 2026
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,946 |  | 4,933
Investments at fair value | 4,946 |  | 4,933
Aerin Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 66 |  | 64
Investments at fair value | $ 1,204 |  | $ 1,200
Number of Shares (in shares) | 1,818,183 |  | 1,818,183
Branded Online, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |  |
Investments at cost | $ 1,079 |  | $ 1,079
Investments at fair value | $ 8 |  | $ 83
Number of Shares (in shares) | 5,398 |  | 108,004
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.75% |  | 13.50%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 8.00% |  | 8.00%
Maturity Date | Jun. 01, 2025 |  | Jun. 01, 2025
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,481 |  | 2,476
Investments at fair value | $ 2,481 |  | $ 2,476
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.75% |  | 13.50%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 8.00% |  | 8.00%
Maturity Date | Jun. 01, 2025 |  | Jun. 01, 2025
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,481 |  | 2,476
Investments at fair value | 2,481 |  | 2,476
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 98 |  | 98
Investments at fair value | $ 125 |  | $ 123
Number of Shares (in shares) | 1,098,805 |  | 605,313
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.75% |  | 13.50%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 8.00% |  | 8.00%
Maturity Date | Jun. 01, 2025 |  | Jun. 01, 2025
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,481 |  | 2,476
Investments at fair value | $ 2,481 |  | $ 2,476
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 14.75% |  | 13.50%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 8.00% |  | 8.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,463 |  | 2,453
Investments at fair value | $ 2,463 |  | $ 2,453
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 14.75% |  | 13.50%
Margin | 6.50% |  | 6.50%
Floor | 9.75% |  | 9.75%
Ceiling | 0.00% |  | 0.00%
ETP | 8.00% |  | 8.00%
Maturity Date | May 01, 2026 |  | May 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,462 |  | 2,455
Investments at fair value | $ 2,462 |  | $ 2,455
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 16.00% |  | 15.25%
Margin | 7.75% |  | 7.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 0.00% |  | 0.00%
Maturity Date | May 01, 2027 |  | Jul. 01, 2025
Principal Amount | $ 1,108 |  | $ 2,500
Investments at cost | 1,086 |  | 2,473
Investments at fair value | $ 868 |  | $ 2,473
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 16.00% |  | 15.25%
Margin | 7.75% |  | 7.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 0.00% |  | 0.00%
Maturity Date | May 01, 2027 |  | Jul. 01, 2025
Principal Amount | $ 554 |  | $ 1,250
Investments at cost | 543 |  | 1,236
Investments at fair value | 434 |  | 1,236
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 32 |  | 32
Investments at fair value | $ 0 |  | $ 22
Number of Shares (in shares) | 171,081 |  | 171,081
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 16.00% |  | 15.25%
Margin | 7.75% |  | 7.75%
Floor | 11.00% |  | 11.00%
Ceiling | 0.00% |  | 0.00%
ETP | 0.00% |  | 0.00%
Maturity Date | May 01, 2027 |  | Jul. 01, 2025
Principal Amount | $ 554 |  | $ 1,250
Investments at cost | 543 |  | 1,236
Investments at fair value | 434 |  | $ 1,236
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 16.93%
Margin |  |  | 9.43%
Floor |  |  | 12.68%
Ceiling |  |  | 0.00%
ETP |  |  | 50.43%
Maturity Date |  |  | Dec. 31, 2022
Principal Amount |  |  | $ 3,295
Investments at cost |  |  | 3,295
Investments at fair value |  |  | 3,295
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost |  |  | 46
Investments at fair value |  |  | $ 0
Number of Shares (in shares) |  |  | 82,967
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] |  |  |
Investments at cost | 2,800 |  |
Investments at fair value | $ 1,281 |  |
Number of Shares (in shares) | 280,000 |  |
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |
Investments at cost |  |  | $ 230
Investments at fair value |  |  | $ 0
Number of Shares (in shares) |  |  | 72,638,663
Updater, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 34 |  | $ 34
Investments at fair value | $ 11 |  | $ 42
Number of Shares (in shares) | 108,333 |  | 108,333
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 12.75%
Margin |  |  | 5.75%
Floor |  |  | 9.00%
Ceiling |  |  | 0.00%
ETP |  |  | 7.00%
Maturity Date |  |  | Nov. 01, 2024
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,475
Investments at fair value |  |  | $ 2,475
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 12.75%
Margin |  |  | 5.75%
Floor |  |  | 9.00%
Ceiling |  |  | 0.00%
ETP |  |  | 7.00%
Maturity Date |  |  | Nov. 01, 2024
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,489
Investments at fair value |  |  | 2,489
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 86 |  | 84
Investments at fair value | $ 1,319 |  | $ 1,864
Number of Shares (in shares) | 12,153 |  | 12,153
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate |  |  | 12.75%
Margin |  |  | 5.75%
Floor |  |  | 9.00%
Ceiling |  |  | 0.00%
ETP |  |  | 7.00%
Maturity Date |  |  | Nov. 01, 2024
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,473
Investments at fair value |  |  | 2,473
Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 21 |  | 22
Investments at fair value | $ 57 |  | $ 312
Number of Shares (in shares) | 71,305 |  | 288,115
Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] |  |  |
Investments at cost | $ 2 |  |
Investments at fair value | $ 193 |  |
Number of Shares (in shares) | 66,127 |  |
CPG Beyond, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 242 |  | $ 242
Investments at fair value | $ 912 |  | $ 909
Number of Shares (in shares) | 500,000 |  | 500,000
Silk, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 175 |  | $ 234
Investments at fair value | $ 148 |  | $ 407
Number of Shares (in shares) | 394,110 |  | 442,110
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 12.50% |  |
Margin | 4.25% |  |
Floor | 12.00% |  |
Ceiling | 0.00% |  |
ETP | 2.50% |  |
Maturity Date | Jun. 01, 2028 |  |
Principal Amount | $ 2,500 |  |
Investments at cost | 2,456 |  |
Investments at fair value | $ 2,456 |  |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 12.50% |  |
Margin | 4.25% |  |
Floor | 12.00% |  |
Ceiling | 0.00% |  |
ETP | 2.50% |  |
Maturity Date | Jun. 01, 2028 |  |
Principal Amount | $ 3,500 |  |
Investments at cost | 3,488 |  |
Investments at fair value | 3,488 |  |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 64 |  |
Investments at fair value | $ 140 |  |
Number of Shares (in shares) | 682 |  |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 12.50% |  |
Margin | 4.25% |  |
Floor | 12.00% |  |
Ceiling | 0.00% |  |
ETP | 2.50% |  |
Maturity Date | Jun. 01, 2028 |  |
Principal Amount | $ 2,500 |  |
Investments at cost | 2,491 |  |
Investments at fair value | $ 2,491 |  |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 12.50% |  |
Margin | 4.25% |  |
Floor | 12.00% |  |
Ceiling | 0.00% |  |
ETP | 2.50% |  |
Maturity Date | Jun. 01, 2028 |  |
Principal Amount | $ 1,500 |  |
Investments at cost | 1,495 |  |
Investments at fair value | 1,495 |  |
Global Worldwide LLC [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 75 |  | $ 75
Investments at fair value | $ 63 |  | $ 0
Number of Shares (in shares) | 245,810 |  | 245,810
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.25% |  | 14.50%
Margin | 7.00% |  | 7.00%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 1.00% |  | 1.00%
Maturity Date | Oct. 01, 2025 |  | Oct. 01, 2025
Principal Amount | $ 5,000 |  | $ 5,000
Investments at cost | 4,972 |  | 4,966
Investments at fair value | $ 4,972 |  | $ 4,966
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.25% |  | 14.50%
Margin | 7.00% |  | 7.00%
Floor | 10.25% |  | 10.25%
Ceiling | 0.00% |  | 0.00%
ETP | 1.00% |  | 1.00%
Maturity Date | Apr. 01, 2026 |  | Apr. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,485 |  | 2,481
Investments at fair value | 2,485 |  | 2,481
Rocket Lawyer Incorporated [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 92 |  | 92
Investments at fair value | $ 360 |  | $ 357
Number of Shares (in shares) | 261,721 |  | 261,721
Cadrenal Therapeutics, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |
Investments at fair value | $ 906 | $ 846 | $ 0
Cadrenal Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Common Stock [Member] |  |  |
Investments at cost | 0 |  |
Investments at fair value | $ 906 |  |
Number of Shares (in shares) | 600,000 |  |
Skillshare, Inc [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 162 |  | 162
Investments at fair value | $ 1,211 |  | $ 802
Number of Shares (in shares) | 139,074 |  | 139,074
CVRx, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost | $ 76 |  | $ 76
Investments at fair value | $ 278 |  | $ 394
Number of Shares (in shares) | 47,410 |  | 47,410
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Sep. 01, 2024 |  | Sep. 01, 2024
Principal Amount | $ 2,333 |  | $ 3,333
Investments at cost | 2,300 |  | 3,286
Investments at fair value | $ 2,300 |  | $ 3,286
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Sep. 01, 2024 |  | Sep. 01, 2024
Principal Amount | $ 2,333 |  | $ 3,333
Investments at cost | 2,300 |  | 3,286
Investments at fair value | 2,300 |  | 3,286
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 364 |  | 364
Investments at fair value | $ 247 |  | $ 243
Number of Shares (in shares) | 344,102 |  | 344,102
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Sep. 01, 2024 |  | Sep. 01, 2024
Principal Amount | $ 1,167 |  | $ 1,667
Investments at cost | 1,149 |  | 1,641
Investments at fair value | $ 1,149 |  | $ 1,641
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Sep. 01, 2024 |  | Sep. 01, 2024
Principal Amount | $ 1,167 |  | $ 1,667
Investments at cost | 1,149 |  | 1,641
Investments at fair value | $ 1,149 |  | $ 1,641
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |
Cash Rate | 14.50% |  | 13.25%
Margin | 6.25% |  | 6.25%
Floor | 9.50% |  | 9.50%
Ceiling | 0.00% |  | 0.00%
ETP | 4.00% |  | 4.00%
Maturity Date | Sep. 01, 2024 |  | Sep. 01, 2024
Principal Amount | $ 1,167 |  | $ 1,667
Investments at cost | 1,129 |  | 1,613
Investments at fair value | $ 1,129 |  | 1,613
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 12.25% |  |
Margin | 4.00% |  |
Floor | 11.75% |  |
Ceiling | 0.00% |  |
ETP | 3.50% |  |
Maturity Date | Jun. 01, 2027 |  |
Principal Amount | $ 5,000 |  |
Investments at cost | 4,762 |  |
Investments at fair value | $ 4,762 |  |
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 12.25% |  |
Margin | 4.00% |  |
Floor | 11.75% |  |
Ceiling | 0.00% |  |
ETP | 3.50% |  |
Maturity Date | Jun. 01, 2027 |  |
Principal Amount | $ 2,500 |  |
Investments at cost | 2,461 |  |
Investments at fair value | 2,461 |  |
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 120 |  |
Investments at fair value | $ 120 |  |
Number of Shares (in shares) | 345,443 |  |
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 12.25% |  |
Margin | 4.00% |  |
Floor | 11.75% |  |
Ceiling | 0.00% |  |
ETP | 3.50% |  |
Maturity Date | Jun. 01, 2027 |  |
Principal Amount | $ 2,500 |  |
Investments at cost | 2,461 |  |
Investments at fair value | 2,461 |  |
Halio, Inc [Member] | Power Management Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 1,585 |  | 1,585
Investments at fair value | $ 2,898 |  | $ 2,610
Number of Shares (in shares) | 5,002,574 |  | 5,002,574
Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost |  |  | $ 56
Investments at fair value |  |  | $ 0
Number of Shares (in shares) |  |  | 6,081
Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred and Common Stock [Member] |  |  |
Investments at cost | $ 57 |  |
Investments at fair value | $ 0 |  |
Number of Shares (in shares) | 6,081 |  |
Meditrina, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 83 |  | $ 83
Investments at fair value | $ 101 |  | $ 101
Number of Shares (in shares) | 233,993 |  | 233,993
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate | 15.00% |  | 13.75%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Mar. 01, 2026 |  | Mar. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,489 |  | 2,421
Investments at fair value | $ 2,489 |  | $ 2,421
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate | 15.00% |  | 13.75%
Margin | 6.75% |  | 6.75%
Floor | 10.00% |  | 10.00%
Ceiling | 0.00% |  | 0.00%
ETP | 5.00% |  | 5.00%
Maturity Date | Mar. 01, 2026 |  | Mar. 01, 2026
Principal Amount | $ 2,500 |  | $ 2,500
Investments at cost | 2,489 |  | 2,487
Investments at fair value | 2,489 |  | 2,487
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 21 |  | 21
Investments at fair value | $ 70 |  | $ 69
Number of Shares (in shares) | 77,828 |  | 77,828
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate | 15.00% |  |
Margin | 6.75% |  |
Floor | 10.00% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Mar. 01, 2027 |  |
Principal Amount | $ 2,500 |  |
Investments at cost | 2,469 |  |
Investments at fair value | $ 2,469 |  |
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate | 15.00% |  |
Margin | 6.75% |  |
Floor | 10.00% |  |
Ceiling | 0.00% |  |
ETP | 3.00% |  |
Maturity Date | Mar. 01, 2027 |  |
Principal Amount | $ 2,500 |  |
Investments at cost | 2,469 |  |
Investments at fair value | 2,469 |  |
E La Carte, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |
Investments at cost |  |  | $ 60
Investments at fair value |  |  | $ 3
Number of Shares (in shares) |  |  | 147,361
E La Carte, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | 60 |  |
Investments at fair value | $ 121 |  |
Number of Shares (in shares) | 147,361 |  |
VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 53 |  | $ 53
Investments at fair value | $ 1 |  | $ 1
Number of Shares (in shares) | 408 |  | 408
Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 13.00%
Margin |  |  | 5.50%
Floor |  |  | 11.00%
Ceiling |  |  | 18.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Dec. 01, 2026
Principal Amount |  |  | $ 5,000
Investments at cost |  |  | 4,798
Investments at fair value |  |  | $ 4,798
Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 13.00%
Margin |  |  | 5.50%
Floor |  |  | 11.00%
Ceiling |  |  | 18.00%
ETP |  |  | 3.00%
Maturity Date |  |  | Dec. 01, 2026
Principal Amount |  |  | $ 5,000
Investments at cost |  |  | 4,948
Investments at fair value |  |  | 4,948
Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | 6
Investments at fair value |  |  | $ 6
Number of Shares (in shares) |  |  | 86,300
Everstream Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 70 |  |
Investments at fair value | $ 70 |  |
Number of Shares (in shares) | 350,000 |  |
Revinate Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 44 |  | $ 46
Investments at fair value | $ 101 |  | $ 99
Number of Shares (in shares) | 682,034 |  | 682,034
Riv Data Corp [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | $ 12
Investments at fair value |  |  | $ 296
Number of Shares (in shares) |  |  | 321,428
SIGNiX, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 225 |  | $ 225
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 186,235 |  | 186,235
Skyword, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |
Investments at cost |  |  | $ 48
Investments at fair value |  |  | $ 1
Number of Shares (in shares) |  |  | 301,055
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 13.50%
Margin |  |  | 6.50%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Feb. 01, 2025
Principal Amount |  |  | $ 3,500
Investments at cost |  |  | 3,472
Investments at fair value |  |  | $ 3,472
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 13.50%
Margin |  |  | 6.50%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Feb. 01, 2025
Principal Amount |  |  | $ 3,500
Investments at cost |  |  | 3,472
Investments at fair value |  |  | 3,472
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | 64
Investments at fair value |  |  | $ 83
Number of Shares (in shares) |  |  | 682
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |
Cash Rate |  |  | 13.50%
Margin |  |  | 6.50%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Dec. 01, 2025
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,472
Investments at fair value |  |  | $ 2,472
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |
Cash Rate |  |  | 13.50%
Margin |  |  | 6.50%
Floor |  |  | 9.75%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Dec. 01, 2025
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,472
Investments at fair value |  |  | 2,472
Topia Mobility, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 138 |  | 138
Investments at fair value | $ 0 |  | $ 0
Number of Shares (in shares) | 3,049,607 |  | 3,049,607
xAd, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost | $ 177 |  | $ 177
Investments at fair value | $ 12 |  | $ 12
Number of Shares (in shares) | 4,343,348 |  | 4,343,348
Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |
Cash Rate |  |  | 13.25%
Margin |  |  | 5.75%
Floor |  |  | 9.00%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Oct. 01, 2025
Principal Amount |  |  | $ 4,943
Investments at cost |  |  | 4,943
Investments at fair value |  |  | $ 1,668
Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |
Cash Rate |  |  | 13.25%
Margin |  |  | 5.75%
Floor |  |  | 9.00%
Ceiling |  |  | 0.00%
ETP |  |  | 4.00%
Maturity Date |  |  | Dec. 31, 2025
Principal Amount |  |  | $ 2,500
Investments at cost |  |  | 2,467
Investments at fair value |  |  | 832
Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |
Investments at cost |  |  | 47
Investments at fair value |  |  | $ 0
Number of Shares (in shares) |  |  | 77,690

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_HealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexElevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwelveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThirteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorinthMedtechIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_ConvertibleDebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorviumIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmbodyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FstarTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsInc1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImvIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InteriorDefineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredAndCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VtvTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketPharmaceuticalsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrandedOnlineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CpgBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CvrxIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GroundspeedAnalyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RivDataCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkywordIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SecureTransfusionServicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |